{{knowledge objective
|Identifiant=OIC-071-13-B
|Item_parent=Eating disorders in adolescents and adults (see item 253)
|Item_parent_short=Eating disorders in adolescents and adults (see item 253)
|Rank=B
|Title=Knowing the principles of pharmacotherapy
|Description=
|Heading=Management
|Contributors=
|Order=13}}
'''Pharmacological management''''

* No drug has marketing authorisation for anorexia nervosa.
* The prescription of psychotropic drugs in the case of co-morbidities must be ''cautious'' (risk of QT prolongation, occurrence of drug dependence).